Marijuana Related Content

Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, including for developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site...

Staci Gruber, PhD, is the director of the Cognitive and Clinical Neuroimaging Core and the Marijuana Investigations for Neuroscientific Discovery (MIND) program at McLean Hospital. She is an associate professor of psychiatry at Harvard Medical School. Her research focuses on the application of...

As an MD, PhD at Osaka University, Dr. Gen Kanayama developed an animal model for Alzheimer’s disease, showing that repeated mild mechanical brain injury may trigger cytoskeletal change, similar to that in human Alzheimer’s disease. He also worked as a staff psychiatrist at Mihara and Sanda Kogen...

Dr. Mary Kathryn (Kate) Dahlgren is an assistant neuroscientist in the Cognitive and Clinical Neuroimaging Core (CCNC) and the Marijuana Investigations for Neuroscientific Discovery (MIND) program, both led by Dr. Staci Gruber. Her work focuses on the impact of both recreational and medical cannabis...

Kelly Sagar, PhD, is a post-doctoral research fellow in the Cognitive and Clinical Neuroimaging Core (CCNC) and Marijuana Investigations for Neuroscientific Discovery (MIND) program, both directed by Dr. Staci Gruber. She joined the CCNC in 2009 as a research assistant, primarily working on studies...